Literature DB >> 28922227

Incidence and Risk Factors of Coagulation Profile Derangement After Liver Surgery: Implications for the Use of Epidural Analgesia-A Retrospective Cohort Study.

Pierre Jacquenod1, Grégoire Wallon1, Mathieu Gazon1, Benjamin Darnis2, Pierre Pradat3, Victor Virlogeux3, Olivier Farges4, Frédéric Aubrun1.   

Abstract

BACKGROUND: Hepatic surgery is a major abdominal surgery. Epidural analgesia may decrease the incidence of postoperative morbidities. Hemostatic disorders frequently occur after hepatic resection. Insertion or withdrawal (whether accidental or not) of an epidural catheter during coagulopathic state may cause an epidural hematoma. The aim of the study is to determine the incidence of coagulopathy after hepatectomy, interfering with epidural catheter removal, and to identify the risk factors related to coagulopathy.
METHODS: We performed a retrospective review of a prospective, multicenter, observational database including patients over 18 years old with a history of liver resection. Main collected data were the following: age, preexisting cirrhosis, Child-Pugh class, preoperative and postoperative coagulation profiles, extent of liver resection, blood loss, blood products transfused during surgery. International normalized ratio (INR) ≥1.5 and/or platelet count <80,000/mm defined coagulopathy according to the neuraxial anesthesia guidelines. A logistic regression analysis was performed to assess the association between selected factors and a coagulopathic state after hepatic resection.
RESULTS: One thousand three hundred seventy-one patients were assessed. Seven hundred fifty-nine patients had data available about postoperative coagulopathy, which was observed in 53.5% [95% confidence interval, 50.0-57.1]. Maximum derangement in INR occurred on the first postoperative day, and platelet count reached a trough peak on postoperative days 2 and 3. In the multivariable analysis, preexisting hepatic cirrhosis (odds ratio [OR] = 2.49 [1.38-4.51]; P = .003), preoperative INR ≥1.3 (OR = 2.39 [1.10-5.17]; P = .027), preoperative platelet count <150 G/L (OR = 3.03 [1.77-5.20]; P = .004), major hepatectomy (OR = 2.96 [2.07-4.23]; P < .001), and estimated intraoperative blood loss ≥1000 mL (OR = 1.85 [1.08-3.18]; P = .025) were associated with postoperative coagulopathy.
CONCLUSIONS: Coagulopathy is frequent (53.5% [95% confidence interval, 50.0-57.1]) after liver resection. Epidural analgesia seems safe in patients undergoing minor hepatic resection without preexisting hepatic cirrhosis, showing a normal preoperative INR and platelet count.

Entities:  

Mesh:

Year:  2018        PMID: 28922227     DOI: 10.1213/ANE.0000000000002457

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  5 in total

1.  A panel of biomarkers in the prediction for early allograft dysfunction and mortality after living donor liver transplantation.

Authors:  Hsin-I Tsai; Chi-Jen Lo; Chao-Wei Lee; Jr-Rung Lin; Wei-Chen Lee; Hung-Yao Ho; Chia-Yi Tsai; Mei-Ling Cheng; Huang-Ping Yu
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

2.  Erector Spinae Plane Blocks in Major Hepatopancreaticobiliary Surgery: A Case Series.

Authors:  Shrijit Nair; Siobhan McGuinness; Fouad Masood; John F Boylan; Niamh P Conlon
Journal:  A A Pract       Date:  2019-11-01

Review 3.  Enhanced recovery after surgery in liver resection: current concepts and controversies.

Authors:  Vandana Agarwal; Jigeeshu V Divatia
Journal:  Korean J Anesthesiol       Date:  2019-03-06

4.  Thoracic Epidural Analgesia for Postoperative Pain Management in Liver Transplantation: A 10-year Study on 685 Liver Transplant Recipients.

Authors:  John Hausken; Håkon Haugaa; Morten Hagness; Pål-Dag Line; Espen Melum; Tor Inge Tønnessen
Journal:  Transplant Direct       Date:  2021-01-07

Review 5.  Perioperative Management of Complex Hepatectomy for Colorectal Liver Metastases: The Alliance between the Surgeon and the Anesthetist.

Authors:  Enrico Giustiniano; Fulvio Nisi; Laura Rocchi; Paola C Zito; Nadia Ruggieri; Matteo M Cimino; Guido Torzilli; Maurizio Cecconi
Journal:  Cancers (Basel)       Date:  2021-05-03       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.